Appointment of Non-executive Director

By

Regulatory News | 23 Jan, 2023

Updated : 23:58

RNS Number : 6026N
Intl. Biotechnology Trust PLC
23 January 2023
 

23 January 2023

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

 

Appointment of Non-executive Director

The Board of the Company is pleased to announce the appointment of Gillian Elcock as a Non-executive Director of the Company with effect from 1 February 2023.

Gillian Elcock is the founder of Denny Ellison, an independent research and analyst training company, and was its Managing Director for ten years. Prior to this, she worked as an equity research analyst for several years at Putnam Investments and Insight Investment. She was named a finalist in the 'Investment Analyst of the Year' category of the Women in Investment Awards 2018. She started her career as a management consultant at The Boston Consulting Group.

Gillian is a member of the Board of the CFA UK and was previously Chair of the society's Networks Steering Committee and a member of its Nominating Committee. She holds an MBA from the Harvard Business School and MEng and BSc degrees from the Massachusetts Institute of Technology.

The following additional information is disclosed in accordance with Chapter 9 of the Financial Conduct Authority Listing Rules:

1.   There are no details to be disclosed under Listing Rule 9.6.13.

2.   As at today's date Gillian Elcock has no beneficial interest in the Ordinary shares of the Company.

  

For further information contact:

 

Broker - Numis

 

Nathan Brown                +44 (0)20 7260 1426 / +44 (0)7795 964 870

 

Vicki Paine                    +44 (0)20 7260 1256 / +44 (0)78 8431 1486

 

 

Company Secretary - Link Company Matters

 

Indu Shastri                   +44 (0)7936 045789

 

 

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGZMNFNGFZM

Last news